Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – t...

by B.H.E. Jansen, Y.J.L. Bodar, G.J.C. Zwezerijnen, J.A. Nieuwenhuijzen, M. Wondergem, T. Roeleveld, O.S. Hoektra, J. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis
Published 2020-07-01

Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies. The SESAME-study

by Y.J.L. Bodar, B.P.F. Koene, D. Meijer, P.J. Van Leeuwen, J.A. Nieuwenhuijzen, R.J.A. Van Moorselaar, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis
Published 2020-11-01

Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: Tumor localizations using PSMA PET/CT imaging

by D. Meijer, M.L. Donswijk, Y.J.L. Bodar, P.J. Van Leeuwen, H.G. Van Der Poel, W.V. Vogel, J.A. Nieuwenhuijzen, N.H. Hendrikse, D.E. Oprea-Lager, A.N. Vis
Published 2020-11-01

Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biops...

by Y.J.L. Bodar, B.H.E. Jansen, P.J. Van Der Voorn, G.J.C. Zwezerijnen, J.A. Nieuwenhuijzen, N.H. Hendrikse, R.J.A. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis
Published 2020-07-01

A protocol for urine collection and storage prior to DNA methylation analysis.

by J Bosschieter, S Bach, I V Bijnsdorp, L I Segerink, W F Rurup, A P van Splunter, I Bahce, P W Novianti, G Kazemier, R J A van Moorselaar, R D M Steenbergen, J A Nieuwenhuijzen
Published 2018-01-01

Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection

by D. Meijer, H. De Barros, Y.J.L. Bodar, P.J. Van Leeuwen, B.H.E. Jansen, T.M. Van Der Sluis, H.G. Van Der Poel, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis
Published 2020-11-01